Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BeyondSpring
BeyondSpring
BeyondSpring is laying off 35% of staff in wake of FDA rejection of lead drug
BeyondSpring is laying off 35% of staff in wake of FDA rejection of lead drug
MedCity News
BeyondSpring
FDA
layoffs
plinabulin
Flag link:
FDA turns down BeyondSpring chemo complication drug, asks for another trial
FDA turns down BeyondSpring chemo complication drug, asks for another trial
Fierce Pharma
BeyondSpring
FDA
small molecule drugs
plinabulin
Flag link:
3 Biotech Stocks With Huge Catalysts Incoming
3 Biotech Stocks With Huge Catalysts Incoming
Motley Fool
BeyondSpring
Allakos
Deciphera
plinabulin
lirentelimab
Qinlock
Flag link:
Plinabulin blooms at last for Beyondspring
Plinabulin blooms at last for Beyondspring
EP Vantage
BeyondSpring
clinical trials
plinabulin
vascular disrupting agents
Flag link:
Second-quarter catalysts for the smaller players
Second-quarter catalysts for the smaller players
EP Vantage
AC Immune
Anavex
Santhera
IMMUTEP
Syndax
Novan
Fulcrum Therapeutics
BeyondSpring
Corbus
Orphazyme
Aldeyra
Adaptimmune
Inflarx
Sutro
Gemini Therapeutics
Flag link:
20,000 leagues for biotech to explore
20,000 leagues for biotech to explore
BioPharma Dive
biotech
bioprospecting
PharmaMar
BeyondSpring
Ohr Pharmaceutical
Wex Pharmaceuticals
Flag link:
